Salmon calcitonin (8-32) reduced(CAS: 151804-77-2)

Salmon calcitonin (8-32) reduced is a peptide with a molecular weight of approximately 1,054 Da. It is a solid with a white or off-white crystalline form. The compound is soluble in water and somewhat less soluble in organic solvents. It exhibits moderate reactivity with basic substances and is stable under neutral conditions. This peptide is typically used in pharmaceutical applications and has a relatively stable nature at room temperature and in aqueous solutions.

Salmon calcitonin (8-32) reduced is synthesized through solid-phase peptide synthesis. The process involves the stepwise addition of amino acids to a growing peptide chain using a protected amino terminal approach. The N-terminal residue is protected, and the synthesis proceeds from the C-terminus. The final peptide is then cleaved from the resin and deprotected, yielding the reduced form. Commonly used protecting groups include Fmoc and Boc, and the synthesis typically achieves high yields and good purity.

Salmon calcitonin (8-32) reduced is primarily used in the pharmaceutical industry. It serves as an active pharmaceutical ingredient (API) in medications aimed at treating osteoporosis and hypercalcemia. The compound is also of interest in biotechnology and research settings, where it is used for its potential therapeutic benefits and for studying calcium homeostasis mechanisms.

When handling Salmon calcitonin (8-32) reduced, it is essential to use appropriate personal protective equipment (PPE), including gloves, laboratory coat, and safety goggles. The compound should be stored in a cool, dry place away from direct sunlight and heat sources. Spills should be managed with care, preferably in a fume hood, using absorbent materials and disposing of waste according to local regulations. Always refer to the Safety Data Sheet (SDS) for specific handling instructions and emergency procedures.